Skip to content
+49 40 3009799 0 order@oncoscience.de
EnglishEnglish
  • DeutschDeutsch
Oncoscience
  • COMPANY
  • ONCOLOGY
  • PRODUCT
  • RESEARCHExpand
    • CLINICAL TRIALS
    • PUBLICATIONS
  • FAQ
  • NEWS
+49 40 3009799 0 
EnglishEnglish
  • DeutschDeutsch
Oncoscience
NEWS

Oncoscience signs contract with YM Biosciences Inc.

ByOncoscience 15. November 200317. July 2025

Read the press release

Download: >> press_release_YM_Biosciences (.pdf 28kB)

Ähnliche Beiträge

Post navigation

NextContinue
AACR annual meeting 2004 – Late breaking news

Similar Posts

NEWS

YM BioSciences’ EGFr antibody receives EU orphan drug designation through Oncoscience AG, its European partner

ByOncoscience 10. August 200417. July 2025

Read More YM BioSciences’ EGFr antibody receives EU orphan drug designation through Oncoscience AG, its European partnerContinue

NEWS

Oncoscience AG and GenIlac agree on cooperation terms in Turkey

ByOncoscience 7. July 201017. July 2025

Read More Oncoscience AG and GenIlac agree on cooperation terms in TurkeyContinue

NEWS

Orphan-Drug-Designation finalised

ByOncoscience 30. June 200417. July 2025

Read More Orphan-Drug-Designation finalisedContinue

NEWS

Funcrypta – Poster presentation at European Bioperspectives

ByOncoscience 4. October 200817. July 2025

Read More Funcrypta – Poster presentation at European BioperspectivesContinue

NEWS

Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher® (Nimotuzumab) in the U.K. and Ireland

ByOncoscience 3. October 201817. July 2025

Read More Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher® (Nimotuzumab) in the U.K. and IrelandContinue

NEWS

Nimotuzumab on ASCO 2022

ByOncoscience 7. June 202217. July 2025

Read More Nimotuzumab on ASCO 2022Continue

Oncoscience GmbH
Osterbrooksweg 59
22869 Schenefeld
Germany

 

Phone: +49-40 300 9799-0
Fax: +49-40 300 9799-20
Email: order@oncoscience.de

part of

Legal Notice

© 2026 Oncoscience

Scroll to top
  • COMPANY
  • ONCOLOGY
  • PRODUCT
  • RESEARCH
    • CLINICAL TRIALS
    • PUBLICATIONS
  • FAQ
  • NEWS
Search
Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OKDatenschutzerklärung